Diagnostic Value of Dynamic <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (<sup>18</sup>F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer

Background and purpose: Dynamic <sup>18</sup>F-FDG PET-CT scanning can accurately quantify <sup>18</sup>F-FDG uptake and has been successfully applied in diagnosing and evaluating therapeutic effects in various malignant tumors. There is no conclusion as to whether it can acc...

Full description

Bibliographic Details
Published in:Diagnostics
Main Authors: Guanglie Li, Shuai Yang, Siyang Wang, Renwei Jiang, Xiwei Xu
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/15/2530
_version_ 1850398036447985664
author Guanglie Li
Shuai Yang
Siyang Wang
Renwei Jiang
Xiwei Xu
author_facet Guanglie Li
Shuai Yang
Siyang Wang
Renwei Jiang
Xiwei Xu
author_sort Guanglie Li
collection DOAJ
container_title Diagnostics
description Background and purpose: Dynamic <sup>18</sup>F-FDG PET-CT scanning can accurately quantify <sup>18</sup>F-FDG uptake and has been successfully applied in diagnosing and evaluating therapeutic effects in various malignant tumors. There is no conclusion as to whether it can accurately distinguish benign and malignant lymph nodes in nasopharyngeal cancer. The main purpose of this study is to reveal the diagnostic value of dynamic PET-CT in cervical lymph node metastasis of nasopharyngeal cancer through analysis. Method: We first searched for cervical lymph nodes interested in static PET-CT, measured their SUV-Max values, and found the corresponding lymph nodes in magnetic resonance images before and after treatment. The valid or invalid groups were included according to the changes in lymph node size before and after treatment. If the change in the product of the maximum diameter and maximum vertical transverse diameter of the lymph node before and after treatment was greater than or equal to 50%, they would be included in the valid group. If the change was less than 50%, they would be included in the invalid group. Their K<sub>i</sub> values were measured on dynamic PET-CT and compared under different conditions. Then, we conducted a correlation analysis between various factors and K<sub>i</sub> values. Finally, diagnostic tests were conducted to compare the sensitivity and specificity of K<sub>i</sub> and SUV-Max. Result: We included 67 cervical lymph nodes from different regions of 51 nasopharyngeal cancer patients and divided them into valid and invalid groups based on changes before treatment. The valid group included 50 lymph nodes, while the invalid group included 17. There wer significant differences (<i>p</i> < 0.001) between the valid and the invalid groups in SUV-Max, K<sub>i</sub>-Mean, and K<sub>i</sub>-Max values. When the SUV-Max was ≤4.5, there was no significant difference in the K<sub>i</sub>-Mean and K<sub>i</sub>-Max between the two groups (<i>p</i> > 0.05). When the SUV-Max was ≤4.5 and pre-treatment lymph nodes were <1.0 cm, the valid group had significantly higher K<sub>i</sub>-Mean (0.00910) and K<sub>i</sub>-Maximum (0.01004) values than the invalid group (K<sub>i</sub>-Mean = 0.00716, K<sub>i</sub>-Max = 0.00767) (<i>p</i> < 0.05). When the SUV-Max was ≤4.5, the pre-treatment lymph nodes < 1.0 cm, and the EBV DNA replication normal, K<sub>i</sub>-Mean (0.01060) and K<sub>i</sub>-Max (0.01149) in the valid group were still significantly higher than the invalid group (K<sub>i</sub>-Mean = 0.00670, K<sub>i</sub>-Max = 0.00719) (<i>p</i> < 0.05). The correlation analysis between different factors (SUV-Max, T-stage, normal EB virus DNA replication, age, and pre-treatment lymph node < 1.0 cm) and the K<sub>i</sub> value showed that SUV-Max and a pre-treatment lymph node < 1.0 cm were related to K<sub>i</sub>-Mean and K<sub>i</sub>-Max. Diagnostic testing was conducted; the AUC value of the SUV-Max value was 0.8259 (95% confidence interval: 0.7296–0.9222), the AUC value of the K<sub>i</sub>-Mean was 0.8759 (95% confidence interval: 0.7950–0.9567), and the AUC value of the K<sub>i</sub>-Max was 0.8859 (95% confidence interval: 0.8089–0.9629). After comparison, it was found that there was no significant difference in AUC values between K<sub>i</sub>-Mean and SUV-Max (<i>p</i> = 0.220 > 0.05), and there was also no significant difference in AUC values between K<sub>i</sub> max and SUV-Max (<i>p</i> = 0.159 > 0.05). By calculating the Youden index, we identified the optimal cut-off value. It was found that the sensitivity of SUV-Max was 100% and the specificity was 66%, the sensitivity of K<sub>i</sub>-Mean was 100% and the specificity was 70%, and the sensitivity of K<sub>i</sub>-Max was 100% and the specificity was 72%. After Chi-Square analysis, it was found that there was no significant difference in specificity between K<sub>i</sub>-Mean and SUV-Max (<i>p</i> = 0.712), and there was also no significant difference in specificity between K<sub>i</sub>-Max and SUV-Max (<i>p</i> = 0.755). Conclusion: Dynamic PET-CT has shown a significant diagnostic value in diagnosing cervical lymph node metastasis of nasopharyngeal cancer, especially for the small SUV value, and lymph nodes do not meet the metastasis criteria before treatment, and EBV DNA replication is normal. Although the diagnostic accuracy, sensitivity, and specificity of dynamic PET-CT were not significantly different from traditional static PET-CT, the dynamic PET-CT had a more accurate tendency.
format Article
id doaj-art-ead3d00571eb4db297c1f087e628bfdc
institution Directory of Open Access Journals
issn 2075-4418
language English
publishDate 2023-07-01
publisher MDPI AG
record_format Article
spelling doaj-art-ead3d00571eb4db297c1f087e628bfdc2025-08-19T22:51:32ZengMDPI AGDiagnostics2075-44182023-07-011315253010.3390/diagnostics13152530Diagnostic Value of Dynamic <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (<sup>18</sup>F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal CancerGuanglie Li0Shuai Yang1Siyang Wang2Renwei Jiang3Xiwei Xu4Department of Head and Neck Oncology, The Fifth Hospital of Sun Yat-sen University, Zhuhai 519000, ChinaDepartment of Radiotherapy Physics, The Fifth Hospital of Sun Yat-sen University, Zhuhai 519000, ChinaDepartment of Head and Neck Oncology, The Fifth Hospital of Sun Yat-sen University, Zhuhai 519000, ChinaDepartment of Radiotherapy Physics, The Fifth Hospital of Sun Yat-sen University, Zhuhai 519000, ChinaDepartment of Head and Neck Oncology, The Fifth Hospital of Sun Yat-sen University, Zhuhai 519000, ChinaBackground and purpose: Dynamic <sup>18</sup>F-FDG PET-CT scanning can accurately quantify <sup>18</sup>F-FDG uptake and has been successfully applied in diagnosing and evaluating therapeutic effects in various malignant tumors. There is no conclusion as to whether it can accurately distinguish benign and malignant lymph nodes in nasopharyngeal cancer. The main purpose of this study is to reveal the diagnostic value of dynamic PET-CT in cervical lymph node metastasis of nasopharyngeal cancer through analysis. Method: We first searched for cervical lymph nodes interested in static PET-CT, measured their SUV-Max values, and found the corresponding lymph nodes in magnetic resonance images before and after treatment. The valid or invalid groups were included according to the changes in lymph node size before and after treatment. If the change in the product of the maximum diameter and maximum vertical transverse diameter of the lymph node before and after treatment was greater than or equal to 50%, they would be included in the valid group. If the change was less than 50%, they would be included in the invalid group. Their K<sub>i</sub> values were measured on dynamic PET-CT and compared under different conditions. Then, we conducted a correlation analysis between various factors and K<sub>i</sub> values. Finally, diagnostic tests were conducted to compare the sensitivity and specificity of K<sub>i</sub> and SUV-Max. Result: We included 67 cervical lymph nodes from different regions of 51 nasopharyngeal cancer patients and divided them into valid and invalid groups based on changes before treatment. The valid group included 50 lymph nodes, while the invalid group included 17. There wer significant differences (<i>p</i> < 0.001) between the valid and the invalid groups in SUV-Max, K<sub>i</sub>-Mean, and K<sub>i</sub>-Max values. When the SUV-Max was ≤4.5, there was no significant difference in the K<sub>i</sub>-Mean and K<sub>i</sub>-Max between the two groups (<i>p</i> > 0.05). When the SUV-Max was ≤4.5 and pre-treatment lymph nodes were <1.0 cm, the valid group had significantly higher K<sub>i</sub>-Mean (0.00910) and K<sub>i</sub>-Maximum (0.01004) values than the invalid group (K<sub>i</sub>-Mean = 0.00716, K<sub>i</sub>-Max = 0.00767) (<i>p</i> < 0.05). When the SUV-Max was ≤4.5, the pre-treatment lymph nodes < 1.0 cm, and the EBV DNA replication normal, K<sub>i</sub>-Mean (0.01060) and K<sub>i</sub>-Max (0.01149) in the valid group were still significantly higher than the invalid group (K<sub>i</sub>-Mean = 0.00670, K<sub>i</sub>-Max = 0.00719) (<i>p</i> < 0.05). The correlation analysis between different factors (SUV-Max, T-stage, normal EB virus DNA replication, age, and pre-treatment lymph node < 1.0 cm) and the K<sub>i</sub> value showed that SUV-Max and a pre-treatment lymph node < 1.0 cm were related to K<sub>i</sub>-Mean and K<sub>i</sub>-Max. Diagnostic testing was conducted; the AUC value of the SUV-Max value was 0.8259 (95% confidence interval: 0.7296–0.9222), the AUC value of the K<sub>i</sub>-Mean was 0.8759 (95% confidence interval: 0.7950–0.9567), and the AUC value of the K<sub>i</sub>-Max was 0.8859 (95% confidence interval: 0.8089–0.9629). After comparison, it was found that there was no significant difference in AUC values between K<sub>i</sub>-Mean and SUV-Max (<i>p</i> = 0.220 > 0.05), and there was also no significant difference in AUC values between K<sub>i</sub> max and SUV-Max (<i>p</i> = 0.159 > 0.05). By calculating the Youden index, we identified the optimal cut-off value. It was found that the sensitivity of SUV-Max was 100% and the specificity was 66%, the sensitivity of K<sub>i</sub>-Mean was 100% and the specificity was 70%, and the sensitivity of K<sub>i</sub>-Max was 100% and the specificity was 72%. After Chi-Square analysis, it was found that there was no significant difference in specificity between K<sub>i</sub>-Mean and SUV-Max (<i>p</i> = 0.712), and there was also no significant difference in specificity between K<sub>i</sub>-Max and SUV-Max (<i>p</i> = 0.755). Conclusion: Dynamic PET-CT has shown a significant diagnostic value in diagnosing cervical lymph node metastasis of nasopharyngeal cancer, especially for the small SUV value, and lymph nodes do not meet the metastasis criteria before treatment, and EBV DNA replication is normal. Although the diagnostic accuracy, sensitivity, and specificity of dynamic PET-CT were not significantly different from traditional static PET-CT, the dynamic PET-CT had a more accurate tendency.https://www.mdpi.com/2075-4418/13/15/2530dynamic PET-CTSUV-maxK<sub>i</sub>-meanK<sub>i</sub>-maxnasopharyngeal cancercervical lymph nodes
spellingShingle Guanglie Li
Shuai Yang
Siyang Wang
Renwei Jiang
Xiwei Xu
Diagnostic Value of Dynamic <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (<sup>18</sup>F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer
dynamic PET-CT
SUV-max
K<sub>i</sub>-mean
K<sub>i</sub>-max
nasopharyngeal cancer
cervical lymph nodes
title Diagnostic Value of Dynamic <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (<sup>18</sup>F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer
title_full Diagnostic Value of Dynamic <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (<sup>18</sup>F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer
title_fullStr Diagnostic Value of Dynamic <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (<sup>18</sup>F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer
title_full_unstemmed Diagnostic Value of Dynamic <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (<sup>18</sup>F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer
title_short Diagnostic Value of Dynamic <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (<sup>18</sup>F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer
title_sort diagnostic value of dynamic sup 18 sup f fluorodeoxyglucose positron emission tomography computed tomography sup 18 sup f fdg pet ct in cervical lymph node metastasis of nasopharyngeal cancer
topic dynamic PET-CT
SUV-max
K<sub>i</sub>-mean
K<sub>i</sub>-max
nasopharyngeal cancer
cervical lymph nodes
url https://www.mdpi.com/2075-4418/13/15/2530
work_keys_str_mv AT guanglieli diagnosticvalueofdynamicsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomographysup18supffdgpetctincervicallymphnodemetastasisofnasopharyngealcancer
AT shuaiyang diagnosticvalueofdynamicsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomographysup18supffdgpetctincervicallymphnodemetastasisofnasopharyngealcancer
AT siyangwang diagnosticvalueofdynamicsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomographysup18supffdgpetctincervicallymphnodemetastasisofnasopharyngealcancer
AT renweijiang diagnosticvalueofdynamicsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomographysup18supffdgpetctincervicallymphnodemetastasisofnasopharyngealcancer
AT xiweixu diagnosticvalueofdynamicsup18supffluorodeoxyglucosepositronemissiontomographycomputedtomographysup18supffdgpetctincervicallymphnodemetastasisofnasopharyngealcancer